Watch Ticker

BioMarin Pharmaceuticals Inc

Go to BioMarin Pharmaceuticals Inc Website

$61.97

1.66 (2.75%)

Live

Previous Close

$61.93

Day Range

$58.72 - $63.97

Previous Day Range

$58 - $60.625

Market Cap

$11.6 billion USD

Day Vol.

7.0 million

Previous Day Vol.

6.7 million

Currency

USD

Primary Exchange

Nasdaq

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Vandana Singh - BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030

BioMarin reported strong Q2 earnings, beating estimates with $1.44 per share and $825.41 million in sales. The company discontinued its preclinical drug candidate BMN 390 but advanced BMN 333 with promising Phase 1 study results, targeting a potential 2030 launch.

Related tickers: BMRN.

Read Full Article

Jesterai - BioMarin (BMRN) Q2 Revenue Jumps 16%

BioMarin Pharmaceutical reported strong Q2 2025 financial results, with GAAP revenue of $825 million, exceeding analyst estimates by 16% year-over-year. The company raised full-year guidance, driven by robust performance of VOXZOGO and Enzyme Therapies, and demonstrated significant growth in profitability.

Related tickers: BMRN.

Read Full Article

Trending Tickers

Please sign in to view